Implementing a Gold Standard FSP Strategic Partnership to Fuel Efficient Drug Development

1 minute read

Webinars

Published: March 7th, 2024

Complete the form below to watch the webinar

Featuring:

  • Francis Kendall, Head of Oncology Statistical Programming, Biometrics, Oncology R&D, AstraZeneca
  • Alan Salter, Director, R&D Clinical Partner Management, Takeda
  • Ping-Chung Chang, Head Business Transformation, Phastar
  • Elisa Mansfield, Vice President, FSP, Phastar

Moderated by Natalie Fforde, Senior Vice President, Global Strategic Partnerships, Phastar

Related articles

SDTM Workflow Transformation: Faster, Easier and More Reliable
Webinars

SDTM Workflow Transformation: Faster, Easier and More Reliable

November 14th, 2025 1 minute read

The demand for rapid, cost-effective, and standards-compliant SDTM delivery continues to increase across the biotech ...

Regulatory-Grade Use of External Data: Bayesian Borrowing, Hybrid Trials and External Controls 
Webinars

Regulatory-Grade Use of External Data: Bayesian Borrowing, Hybrid Trials and External Controls 

November 5th, 2025 1 minute read

Use of external data to augment clinical trials has been increasingly evaluated and is transforming drug development ...

Early Phase Clinical Trials: Key Considerations for Drug Development Pipelines
Webinars

Early Phase Clinical Trials: Key Considerations for Drug Development Pipelines

October 30th, 2025 1 minute read

The early stages of clinical development are critical, decisions made here can determine the efficiency, cost, and ul...